Advertisement
UK markets close in 7 hours
  • FTSE 100

    8,088.65
    +48.27 (+0.60%)
     
  • FTSE 250

    19,675.20
    -44.17 (-0.22%)
     
  • AIM

    754.57
    -0.12 (-0.02%)
     
  • GBP/EUR

    1.1664
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.2514
    +0.0052 (+0.42%)
     
  • Bitcoin GBP

    51,148.12
    -2,135.84 (-4.01%)
     
  • CMC Crypto 200

    1,363.80
    -18.77 (-1.36%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.16
    +0.35 (+0.42%)
     
  • GOLD FUTURES

    2,338.40
    0.00 (0.00%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    18,024.73
    -63.97 (-0.35%)
     
  • CAC 40

    8,068.61
    -23.25 (-0.29%)
     

Why Healthcare Could Be a Make-or-Break Strategy for Walgreens

Why Healthcare Could Be a Make-or-Break Strategy for Walgreens

Walgreens Boots Alliance (NASDAQ: WBA) has made for a disappointing investment to hold over the past five years. While Walgreens does offer a high yield of 4.6%, that may be of little comfort to investors who have incurred such significant losses. Whether the next five years will be any better for the stock will likely depend on the company's healthcare strategy.